Counterfeit Drugs
(1999; 61 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentExecutive Summary
Open this folder and view contents1. Introduction
View the document2. Overview of the problem
View the document3. Impact on public health
View the document4. Factors facilitating counterfeiting
Open this folder and view contents5. Developing national strategies
Open this folder and view contents6. Specific measures
Open this folder and view contents7. Assessment of the problem at the national level
Open this folder and view contents8. Inspection when pharmaceutical products are suspected to be counterfeit, spurious or substandard
Open this folder and view contents9. Test methods
Close this folder10. Developing training programmes: inspection and examination of counterfeit pharmaceuticals
View the document10.1 General remarks
View the document10.2 Training programme on inspection
View the document10.3 Training programme on examination
View the document10.4 The practical issues of organizing and implementing the programme (35)
View the document11. Conclusion
View the documentReferences
View the documentSelected further reading
View the documentAcknowledgements
View the documentGlossary
 

10.3 Training programme on examination

Course objectives

The aim of this course is to provide trainees with:

- an awareness of the importance of examining suspect pharmaceuticals in order to facilitate the inspector's decision whether or not to act

- sufficient knowledge and skills to examine counterfeit pharmaceuticals

- an understanding of the difference between counterfeit and substandard drugs

- knowledge of the value and limitations of techniques for rapid examination, and the ability to make rational decisions about their use

- the ability to justify legal action in the context of detection and prosecution.

Types of training

Theory and practice involving examination of drugs.

Educational background of trainees and trainers

Previous or formal training of trainees is not absolutely required for the examination of drugs, but former training would be advantageous. Preferably, trainees should meet the following criteria, according to country requirements:

- knowledge of and competence in selected laboratory techniques, such as using a weighing balance and volumetric measurements, and the ability to perceive differences in colours

- reading and writing skills to facilitate adequate record-keeping

- an understanding of the need and the willingness to work as a team and to share information.

The trainer should be experienced and have full knowledge of general and official analytical methods. Furthermore, he or she should be able to conduct and design, when necessary, the training programme. Other characteristics include:

- an appreciation of the role of chemical testing in the legal system for combating counterfeit products

- an understanding of the difference between counterfeit and substandard drugs

- knowledge of the latest statistics on the prevalence of counterfeit pharmaceuticals in the country, if possible

- knowledge of relevant quality standards

- knowledge of characteristics of various dosage forms

- thorough overall knowledge of the subjects to be taught.

Course programme items

The following items should be included in the course; the actual content of each item will depend on the prior experience of the trainees (see Box 4).

Box 4
Course programme items for examiners

- overview of relevant legislation

- national drug regulatory systems, inspection and quality control

- drug distribution systems

- illegal distribution channels

- types of counterfeit pharmaceuticals encountered

- general characteristics of various dosage forms, such as active ingredient to excipient ratio in tablets, capsules, ampoules, powder for injection, ointments, creams, etc.

- sampling methods

- reference substances and working standards: importance and maintenance

- reference data in books or electronic form (e.g. Internet)

- security aspects

- record-keeping, the importance of properly documented laboratory work including description of samples

- preparation of official reports

- relations with WHO

- examination techniques (see below)

After demonstration of the techniques to be used, trainees should practice with an adequate number of known dosage forms, preferably including capsules, tablets, injectable preparations and ointments. Trainees will then test unknown samples, report on their work and draw conclusions as to whether the samples are counterfeit or require additional analysis. The results will be compared with previously determined data and will be discussed in the group.

In the course, the trainee will be taught to perform various examinations including:

- examination of labelling features, packaging materials and packaging of various drug forms

- measurement of various physical properties of the product

- thin-layer chromatography

- other specifically selected examination procedures.

Duration of course

Duration of the course depends on the local situation. A typical course would take about 10 days, consisting of:

- introduction (1-2 days)

- theory (1-2 days)

- practical work in the laboratory and field, if necessary on various dosage forms (4 days)

- preparation of a summary and reporting (2 days).

Reiterative training

Refresher courses should be regularly organized and attended. Country demand would determine the frequency of these courses.

Assessment

Continuous assessment will be conducted during the programme.

Certificate

An appropriate certificate should be issued on satisfactory completion of all parts of the programme.

Evaluation of the programme

Evaluation is an important component of any such activity, particularly since the occurrence and nature of counterfeiting differ from country to country. This may result in changes in the activities of inspectors. Therefore, a refresher course could be of a different nature if so indicated by evaluation.

Document kit

Trainees should be supplied with a document kit which should include references (26)-(28) and (32).

to previous section to next section
 

Last updated: May 3, 2013